Nanobody Market According to MRFR analysis, the global nanobody market share is expected to register a CAGR of 24.2% from 2022 to 2030 and hold a value of over USD 1.14 billion by 2030 The global market of nanobody is driven by various factors, such as rising healthcare expenditure and increasing investments in R&D activities to develop nanobody-based therapeutics. In addition,...

Nanobody Market According to MRFR analysis, the global nanobody market share is expected to register a CAGR of 24.2% from 2022 to 2030 and hold a value of over USD 1.14 billion by 2030 The global market of nanobody is driven by various factors, such as rising healthcare expenditure and increasing investments in R&D activities to develop nanobody-based therapeutics. In addition,...

The Asia-Pacific region is experiencing a surge in the nanobody market, reflecting a growing interest in advanced biotechnology. Nanobodies, which are small antigen-binding fragments derived from camelid antibodies, have garnered significant attention due to their numerous advantages over traditional antibodies. In the Asia-Pacific Nanobody Market, the demand for these innovative biologics...